Proposed Data Collections Submitted for Public Comment and Recommendations, 53428-53430 [2014-21379]

Download as PDF 53428 Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Avg. burden per response (in hrs.) Type of respondents Form name State Education Agency ......... Exemplary Sexual Health Education Measures ..................... Sexual Health Services Measures ......................................... Safe and Supportive Environments Measures ...................... Exemplary Sexual Health Education Measures ..................... Sexual Health Services Measures ......................................... Safe and Supportive Environments Measures ...................... Exemplary Sexual Health Education Measures ..................... 19 19 19 17 17 17 2 2 2 2 2 2 2 2 4 3 1 6 3 6 30/60 Sexual Health Services Measures ......................................... Safe and Supportive Environments Measures ...................... 2 2 2 2 30/60 30/60 Local Education Agency ......... Non-governmental organization. Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–21377 Filed 9–8–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–14–14AVQ] tkelley on DSK3SPTVN1PROD with NOTICES Proposed Data Collections Submitted for Public Comment and Recommendations The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. To request more information on the below proposed project or to obtain a copy of the information collection plan and instruments, call 404–639–7570 or send comments to Leroy A. Richardson, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments submitted in response to this notice will be summarized and/or included in the request for Office of Management and Budget (OMB) approval. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to VerDate Mar<15>2010 17:39 Sep 08, 2014 Jkt 232001 minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Written comments should be received within 60 days of this notice. Proposed Project Returning Our Veterans to Employment and Reintegration (ROVER): Work Stress and Assistance Animals—New—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description Veterans with chronic posttraumatic stress disorder (PTSD) face barriers that prevent many of them from successfully reintegrating into society and returning to the work force. Various reports claim that higher unemployment rates and increased healthcare costs and utilization are associated with PTSD. Symptoms associated with PTSD include diminished interest or participation in significant activities, feelings of detachment or estrangement from others, difficulty falling or staying PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 asleep, hyper vigilance, exaggerated startle response, difficulty with concentration or attention, and a restricted range of affect. Amelioration of PTSD symptoms is necessary to facilitate reintegration of veterans into society and the workforce; these benefits may also contribute positively to veterans’ overall physical and psychological health. A review of mostly anecdotal evidence suggests that animal-assisted interventions may have general therapeutic benefits for individuals with PTSD. Although a few reports tout the benefits of human-animal companionship, no studies have focused specifically on investigating the elements of human-animal interactions that might be therapeutic for individuals with PTSD or other stress-related disorders. Furthermore, there is scant evidence supporting the notion that service dogs or therapy dogs may directly improve functioning and, thereby, ease an individual’s reintegration into society and employment. NIOSH is seeking a 3-year approval from OMB on a research study aimed at understanding the benefits of humananimal interactions for the purpose of facilitating the reintegration and employment of veterans with PTSD. The efficacy of using service dogs or other types of assistance dogs to help veterans with disabilities return to work has not been established in well-controlled scientific studies, and fundamental empirical evidence is scant. As a step toward a greater understanding, a laboratory-based work-simulation study will be conducted to investigate the influence of the presence of and interactions with a dog on the reactivity and performance of veterans with and without PTSD to work-related and startle stressors. Results of the laboratory-based study will complement the findings of another project (OMB No. 09200985), which is gathering information about veterans perceptions E:\FR\FM\09SEN1.SGM 09SEN1 53429 Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices of the barriers and facilitators to reintegration through two national Webbased surveys. There is no duplication of effort or burden because the research objectives and research methods are substantial different. This study will be conducted at the NIOSH research facility in Morgantown, WV, which includes state-of-the-art laboratories and equipment to simulate work-related stress under controlled conditions and will use a small-n experimental design with multiple, repeated assessments over time to measure the behavioral (work performance), psychological, and physiological responses of participants. The role of dogs in potentially moderating the effects of the stressors will be investigated with either the absence or presence of a dog in some conditions and a dog that is either familiar or unfamiliar to the veteran in other conditions. The general working hypothesis is that the presence of, and/ or interaction with, a familiar dog reduces stress and enhances work performance for both veterans with and flyers and complete the initial Webbased contact form and several prescreening forms, including the Pet Attitude Scale, the Combat Exposure Scale, PTSD Checklist, Medication List, Drug Abuse Screening Test, Center for Epidemiological Studies Depression Scale, Short Michigan Alcoholism Screening Tool, and the World Health Organization Quality of Life Index Brief. A total of 64 eligible veterans from this pool are expected to be enrolled in the laboratory portion of the study, including at least 16 veterans who own a service dog. Upon entering the study, all enrolled veterans will complete the Positive and Negative Affect Scale on site, and veterans with service dogs will complete the Big Five Inventory (BFI), the Canine Behavioral Assessment and Research Questionnaire (CBARQ), the Pet Attachment and Life Impact Scale (PALS), Dog Personality Scale (DPQ), and the Social Style-Self and the Social Style-Service Dog questionnaires. There are no costs to respondents other than their time. without PTSD, with a greater benefit to veterans with PTSD. U.S. Veterans, with and without PTSD, and veterans with service dogs will be recruited with the assistance of various veterans’ organizations to participate in this research study. During the initial recruitment phase, veterans who receive and respond to the recruitment announcements will complete several Web-based prescreening questionnaires, and eligible veterans, who are enrolled into the research study, will complete additional questionnaires and tasks in multi-day assessment sessions at the NIOSH Morgantown facility. An estimated 400 persons in various veterans’ agencies will receive email announcements of the research study and follow-up phone calls. The work activity associated with reading the email, answering the phone calls, and distributing a study announcement/flyer to additional individuals is estimated to take up to 10 minutes for each occurrence. Approximately 200 veterans are expected to see the recruitment ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Representatives of veterans organizations. Veterans ............................................ Veterans ............................................ Veterans ............................................ Veterans ............................................ Veterans Study Announcement Email/Phone Contact. Recruitment Flyer ............................. Contact Form ................................... Pre-Screening Pet Attitude Scale .... Pre-Screening Combat Exposure Scale. Pre-Screening PTSD Checklist ........ Pre-Screening Medication List ......... Pre-Screening Drug Abuse Screening Test. Pre-Screening Center for Epidemiolo-gical Studies Depression Scale. Pre-Screening Short Michigan Alcoholism Screening Tool. Pre-Screening World Health Organization Quality of Life Index Brief. Positive and Negative Affect Scale (PANAS). PANAS ............................................. NASA Task Load Index (NASA TLX) Average burden per response (in hours) Total burden hours 400 1 10/60 67 200 64 64 64 1 1 1 1 10/60 10/60 5/60 5/60 33 11 5 5 64 64 64 1 1 1 5/60 5/60 5/60 5 5 5 64 1 5/60 5 64 1 5/60 5 64 1 10/60 11 48 3 2/60 5 16 48 6 2 2/60 2/60 3 5 16 16 16 4 1 1 2/60 10/60 10/60 2 3 3 16 1 10/60 3 Enrolled Veterans with Service Dogs Enrolled Veterans with Service Dogs Enrolled Veterans with Service Dogs NASA TLX ........................................ Big Five Inventory (BFI) ................... Canine Behavioral Assessment and Research Questionnaire (CBARQ). Pet Attachment and Life Impact Scale (PALS). Dog Personality Scale (DPQ) .......... Social Style-Self ............................... Social Style-Service Dog ................. 16 16 16 1 1 1 10/60 10/60 10/60 3 3 3 Total ........................................... ........................................................... ........................ ........................ ........................ 190 Veterans ............................................ Veterans ............................................ Veterans ............................................ Veterans ............................................ Veterans ............................................ Veterans ............................................ Enrolled Dogs. Enrolled Enrolled Dogs. Enrolled Enrolled Enrolled Veterans without Service Veterans with Service Dogs Veterans without Service Veterans with Service Dogs Veterans with Service Dogs Veterans with Service Dogs Enrolled Veterans with Service Dogs tkelley on DSK3SPTVN1PROD with NOTICES Number of responses per respondent VerDate Mar<15>2010 17:39 Sep 08, 2014 Jkt 232001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\09SEN1.SGM 09SEN1 53430 Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–21379 Filed 9–8–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Georgia Tuberculosis Outbreak Among Homeless Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). AGENCY: ACTION: Notice of award. The Centers for Disease Control and Prevention (CDC) located within the United States Department of Health and Human Services (HHS) announces a notice of award to the Georgia Department of Public Health, Tuberculosis (TB) Program. This award will be in the amount of $419,095.00. The purpose of this award is to halt the further spread of a drug-resistant strain of tuberculosis associated with multiple homeless shelters in Fulton County, Georgia. SUMMARY: It is expected the notice of award will begin on or about September 3, 2014. The project period will be for one year. FOR FURTHER INFORMATION CONTACT: Gail Burns-Grant, Division of Tuberculosis Elimination, Field Services and Evaluation Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS E–10, Atlanta, GA 30333; phone: 404–639–5344; email: GAB2@ cdc.gov. SUPPLEMENTARY INFORMATION: Currently, the state of Georgia is experiencing a public health emergency in Fulton County where there has been extensive transmission of a drug-resistant strain of tuberculosis (TB) associated with multiple homeless shelters in the county. The Georgia Department of Public Health asked CDC to provide emergency funding for the immediate implementation of CDC recommendations provided as a result of a May 2014 outbreak investigation to prevent further transmission of this drug-resistant strain of tuberculosis and to prevent further deaths associated with this outbreak. Project number is CDC–RFA–PS14–1416. DATES: Dated: September 4, 2014. Ron A. Otten, Acting Deputy Associate Director for Science, Centers for Disease Control and Prevention. [FR Doc. 2014–21455 Filed 9–4–14; 4:15 pm] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2014–N–0001] Advisory Committee Renewals; Correction AGENCY: Food and Drug Administration, HHS. ACTION: Notice; correction. The Food and Drug Administration (FDA) is correcting a notice entitled ‘‘Advisory Committee Renewals’’ that appeared in the Federal Register of August 25, 2014 (79 FR 50658). The document announced the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs. The table in the document contained several errors. This document corrects those errors. SUMMARY: Lisa Granger, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3330, Silver Spring, MD 20993–0002, 301–796–9115. FOR FURTHER INFORMATION CONTACT: In the Federal Register of Monday, August 25, 2014, in FR Doc. 2014–20017, on page 50659 the table is corrected to read: SUPPLEMENTARY INFORMATION: Name of committee Date of expiration Advisory Committee for Pharmaceutical Science and Clinical Pharmacology ....................................................................... Gastrointestinal Drugs Advisory Committee ............................................................................................................................ Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Reproductive Health Drugs Advisory Committee) Arthritis Advisory Committee ................................................................................................................................................... Pharmacy Compounding Advisory Committee ........................................................................................................................ Anesthetic and Analgesic Drugs Advisory Committee ............................................................................................................ Blood Products Advisory Committee ....................................................................................................................................... Pulmonary-Allergy Drugs Advisory Committee ....................................................................................................................... Drug Safety and Risk Management Advisory Committee ....................................................................................................... Science Advisory Board to the National Center for Toxicological Research .......................................................................... Peripheral and Central Nervous System Drugs Advisory Committee .................................................................................... Psychopharmacologic Drugs Advisory Committee ................................................................................................................. Transmissible and Spongiform Encephalopathies Advisory Committee ................................................................................. Science Board to the Food and Drug Administration ............................................................................................................. Allergenic Products Advisory Committee ................................................................................................................................ Dated: September 3, 2014. Jill Hartzler Warner, Associate Commissioner for Special Medical Programs. DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES [Docket No. FDA–2014–N–1049] Exploring the Expansion of Conditional Approval to Appropriate Categories of New Animal Drugs AGENCY: Food and Drug Administration, HHS. VerDate Mar<15>2010 17:39 Sep 08, 2014 Jkt 232001 Notice. The Food and Drug Administration (FDA) is announcing that it is beginning the exploration process described in a stated performance goal in the Animal Drug User Fee Amendments of 2013 (ADUFA III) goals letter. Consistent with the performance goal, the FDA is inviting comments in regard to the Agency exploring the use of statutory changes to expand the use of conditional approval SUMMARY: Food and Drug Administration [FR Doc. 2014–21369 Filed 9–8–14; 8:45 am] BILLING CODE 4164–01–P ACTION: PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 January 22, 2016. March 3, 2016. March 23, 2016. April 5, 2016. April 25, 2016. May 1, 2016. May 13, 2016. May 30, 2016. May 31, 2016. June 2, 2016. June 4, 2016. June 4, 2016. June 9, 2016. June 26, 2016. July 9, 2016. E:\FR\FM\09SEN1.SGM 09SEN1

Agencies

[Federal Register Volume 79, Number 174 (Tuesday, September 9, 2014)]
[Notices]
[Pages 53428-53430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21379]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-14-14AVQ]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or 
send an email to omb@cdc.gov.
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    Returning Our Veterans to Employment and Reintegration (ROVER): 
Work Stress and Assistance Animals--New--National Institute for 
Occupational Safety and Health (NIOSH), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    Veterans with chronic posttraumatic stress disorder (PTSD) face 
barriers that prevent many of them from successfully reintegrating into 
society and returning to the work force. Various reports claim that 
higher unemployment rates and increased healthcare costs and 
utilization are associated with PTSD.
    Symptoms associated with PTSD include diminished interest or 
participation in significant activities, feelings of detachment or 
estrangement from others, difficulty falling or staying asleep, hyper 
vigilance, exaggerated startle response, difficulty with concentration 
or attention, and a restricted range of affect. Amelioration of PTSD 
symptoms is necessary to facilitate reintegration of veterans into 
society and the workforce; these benefits may also contribute 
positively to veterans' overall physical and psychological health.
    A review of mostly anecdotal evidence suggests that animal-assisted 
interventions may have general therapeutic benefits for individuals 
with PTSD. Although a few reports tout the benefits of human-animal 
companionship, no studies have focused specifically on investigating 
the elements of human-animal interactions that might be therapeutic for 
individuals with PTSD or other stress-related disorders. Furthermore, 
there is scant evidence supporting the notion that service dogs or 
therapy dogs may directly improve functioning and, thereby, ease an 
individual's reintegration into society and employment.
    NIOSH is seeking a 3-year approval from OMB on a research study 
aimed at understanding the benefits of human-animal interactions for 
the purpose of facilitating the reintegration and employment of 
veterans with PTSD. The efficacy of using service dogs or other types 
of assistance dogs to help veterans with disabilities return to work 
has not been established in well-controlled scientific studies, and 
fundamental empirical evidence is scant. As a step toward a greater 
understanding, a laboratory-based work-simulation study will be 
conducted to investigate the influence of the presence of and 
interactions with a dog on the reactivity and performance of veterans 
with and without PTSD to work-related and startle stressors. Results of 
the laboratory-based study will complement the findings of another 
project (OMB No. 09200985), which is gathering information about 
veterans perceptions

[[Page 53429]]

of the barriers and facilitators to reintegration through two national 
Web-based surveys. There is no duplication of effort or burden because 
the research objectives and research methods are substantial different.
    This study will be conducted at the NIOSH research facility in 
Morgantown, WV, which includes state-of-the-art laboratories and 
equipment to simulate work-related stress under controlled conditions 
and will use a small-n experimental design with multiple, repeated 
assessments over time to measure the behavioral (work performance), 
psychological, and physiological responses of participants. The role of 
dogs in potentially moderating the effects of the stressors will be 
investigated with either the absence or presence of a dog in some 
conditions and a dog that is either familiar or unfamiliar to the 
veteran in other conditions. The general working hypothesis is that the 
presence of, and/or interaction with, a familiar dog reduces stress and 
enhances work performance for both veterans with and without PTSD, with 
a greater benefit to veterans with PTSD.
    U.S. Veterans, with and without PTSD, and veterans with service 
dogs will be recruited with the assistance of various veterans' 
organizations to participate in this research study. During the initial 
recruitment phase, veterans who receive and respond to the recruitment 
announcements will complete several Web-based prescreening 
questionnaires, and eligible veterans, who are enrolled into the 
research study, will complete additional questionnaires and tasks in 
multi-day assessment sessions at the NIOSH Morgantown facility. An 
estimated 400 persons in various veterans' agencies will receive email 
announcements of the research study and follow-up phone calls. The work 
activity associated with reading the email, answering the phone calls, 
and distributing a study announcement/flyer to additional individuals 
is estimated to take up to 10 minutes for each occurrence. 
Approximately 200 veterans are expected to see the recruitment flyers 
and complete the initial Web-based contact form and several pre-
screening forms, including the Pet Attitude Scale, the Combat Exposure 
Scale, PTSD Checklist, Medication List, Drug Abuse Screening Test, 
Center for Epidemiological Studies Depression Scale, Short Michigan 
Alcoholism Screening Tool, and the World Health Organization Quality of 
Life Index Brief. A total of 64 eligible veterans from this pool are 
expected to be enrolled in the laboratory portion of the study, 
including at least 16 veterans who own a service dog. Upon entering the 
study, all enrolled veterans will complete the Positive and Negative 
Affect Scale on site, and veterans with service dogs will complete the 
Big Five Inventory (BFI), the Canine Behavioral Assessment and Research 
Questionnaire (CBARQ), the Pet Attachment and Life Impact Scale (PALS), 
Dog Personality Scale (DPQ), and the Social Style-Self and the Social 
Style-Service Dog questionnaires.
    There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondent            Form name       respondents    responses per   response (in        hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Representatives of veterans     Veterans Study               400               1           10/60              67
 organizations.                  Announcement
                                 Email/Phone
                                 Contact.
Veterans......................  Recruitment                  200               1           10/60              33
                                 Flyer.
Veterans......................  Contact Form....              64               1           10/60              11
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Pet Attitude
                                 Scale.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Combat Exposure
                                 Scale.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 PTSD Checklist.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Medication List.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Drug Abuse
                                 Screening Test.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Center for
                                 Epidemiolo-
                                 gical Studies
                                 Depression
                                 Scale.
Veterans......................  Pre-Screening                 64               1            5/60               5
                                 Short Michigan
                                 Alcoholism
                                 Screening Tool.
Veterans......................  Pre-Screening                 64               1           10/60              11
                                 World Health
                                 Organization
                                 Quality of Life
                                 Index Brief.
Enrolled Veterans without       Positive and                  48               3            2/60               5
 Service Dogs.                   Negative Affect
                                 Scale (PANAS).
Enrolled Veterans with Service  PANAS...........              16               6            2/60               3
 Dogs.
Enrolled Veterans without       NASA Task Load                48               2            2/60               5
 Service Dogs.                   Index (NASA
                                 TLX).
Enrolled Veterans with Service  NASA TLX........              16               4            2/60               2
 Dogs.
Enrolled Veterans with Service  Big Five                      16               1           10/60               3
 Dogs.                           Inventory (BFI).
Enrolled Veterans with Service  Canine                        16               1           10/60               3
 Dogs.                           Behavioral
                                 Assessment and
                                 Research
                                 Questionnaire
                                 (CBARQ).
Enrolled Veterans with Service  Pet Attachment                16               1           10/60               3
 Dogs.                           and Life Impact
                                 Scale (PALS).
Enrolled Veterans with Service  Dog Personality               16               1           10/60               3
 Dogs.                           Scale (DPQ).
Enrolled Veterans with Service  Social Style-                 16               1           10/60               3
 Dogs.                           Self.
Enrolled Veterans with Service  Social Style-                 16               1           10/60               3
 Dogs.                           Service Dog.
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr                  ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             190
----------------------------------------------------------------------------------------------------------------



[[Page 53430]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-21379 Filed 9-8-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.